Abstract: The present invention provides a system and method for sending a cellular text message to a system server through a data network, including an identification of a requested database record and a forward address. The system server then performs a database lookup or related search and sends an enhanced message or a file to the forward address, which could be a cellular phone, e-mail address, server, computer, mobile device, or any hardware or device associated with the intended recipient that is communicatively coupled to the system server.

Abstract: Provided herein are methods for administering an efficacious amount of a compound of Formula I that reduce the severity of a potential adverse effect or obviate a potential adverse effect.

Abstract: A method for producing a single crystal ingot includes steps of providing a first amount of polycrystalline material and a first amount of dopant material to form a first mixture having a first dopant concentration in a process furnace, increasing a temperature of the first mixture to provide a molten first mixture, providing a seed material to the molten first mixture, withdrawing the seed from the molten first mixture by a first distance to form a boule having a first length, providing a second amount of the polycrystalline material and a second amount of the dopant material to the molten first mixture to provide a molten second mixture having the first dopant concentration, withdrawing the first length of the boule from the molten second mixture by a second distance to form the boule having a second length, and removing the boule from the molten second mixture to form the single crystal ingot of uniform axial resistivity.

Abstract: N-(Sulfonyloxybiarylmethyl)aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.

Abstract: The present disclosure provides methods of synthesizing alkylating agents and methods of use.

Abstract: In a transdermal drug delivery system, encapsulation material used to coat drug granules controls the release of an active ingredient. The active ingredient is released into a water retaining matrix, which acts as a reservoir, and transdermal drug penetration is driven by the resulting concentration gradient. The delivery system is enclosed in a patch comprising a composite shell, which acts as an occlusive covering when attached to skin, thus enhancing the hydration of the skin area and fostering absorption of the drug. Visible change indicators incorporated into the system provide indicators at significant "landmarks" in the lifetime of the patch. Microcapsules used for the indicator may be formulated so that the penetration of moisture effects a color change at a time when the active ingredient is almost exhausted. This feature alerts to the user to the need for application of a replacement patch.

Abstract: In a transdermal drug delivery system, encapsulation material used to coat drug granules controls the release of an active ingredient. The active ingredient is released into a water retaining matrix, which acts as a reservoir, and transdermal drug penetration is driven by the resulting concentration gradient. The delivery system is enclosed in a patch comprising a composite shell, which acts as an occlusive covering when attached to skin, thus enhancing the hydration of the skin area and fostering absorption of the drug. Visible change indicators incorporated into the system provide indicators at significant "landmarks" in the lifetime of the patch. Microcapsules used for the indicator may be formulated so that the penetration of moisture effects a color change at a time when the active ingredient is almost exhausted. This feature alerts to the user to the need for application of a replacement patch.

Abstract: This invention relates to exchanging the sodium contained in a crystalline zeolite by partially removing sodium by exchange with another cation, partially drying the exchanged zeolite and re-exchanging the dried zeolite.

Abstract: This invention relates to a process for production of catalyst substrates and catalysts of calibrated pore size distribution by incorporation in and removal of particles of determined particle size from substrate or catalyst formulations.

Abstract: An improvement in abrasion resistance is obtained in zeolite compositions containing alumina and clay in a matrix by employing comminuted zeolites.

Abstract: This invention relates to a method of producing a zeolite containing cracking catalyst by employing a sodium silicate derived silica gel in combination with clay to form a catalyst having a good attrition resistance, low carbon, and hydrogen forming properties.

Abstract: This invention relates to improvements in the processes of exchanging zeolites, particularly zeolites of the faujasite type to reduce their sodium content by a multiple exchange under autogenous superatmospheric pressure.

Abstract: The catalyst of this invention is composed of an exchanged zeolite of the faujasite type composited with a matrix composed of clay, alumina and silica added as sodium silicate, the added silica being in the range of about 0.5% to less than about 3.5% based on the composite catalyst on a volatile free basis.

Abstract: This invention relates to an improvement in the abrasion resistance of catalysts formulated from a mixture of an exchanged zeolite of the faujasite type, hydrated alumina and ammonium polysilicate or silica sol.

Abstract: Attrition resistant zeolitic catalysts containing silica, alumina and clay components.